Kangbuk Samsung Hospital
Kangbuk Samsung Hospital
Seoul, South Korea1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy | HER2-positive Advanced Gastric Cancer | Recruiting | Phase 1 / Phase 2 | 2024-11-26 | NCT05640830 |